CV

Curriculum Vitae

Dr. Cica Vissiennon

Overall Scientific Expertise

Educational background in pharmacy with a PhD in pharmacology. Past professional involvement focused on research activities in the field of pharmacology and pharmacokinetics of herbal medicines and phytochemicals at the University of Florida and the University of Leipzig, and regulatory activities in the field of traditional herbal medicines in Europe at the European Medicines Agency - HMPC (Committee on Herbal Medicinal Products) secretariat and the Commission E for Herbal Medicinal Products at the Federal Institute for Drugs and Medical Devices. As an Advisory Board member of the “Society for Medicinal Plant and Natural Product Research”, she chairs the committee “African Research Network”, which aims to foster the North-South dialogue by strengthening the partnership between Europe and Africa.

Education/Professional Experience

since 2017 Research group leader (Leipzig University, Institute for Medical Physics and Biophysics)
2015 - 2017 Post-doctoral fellow (Leipzig University, Institute for Medical Physics and Biophysics)
2015 Doctorate (Dr. rer. nat.) (Leipzig University)
2011 - 2015 Doctoral candidate (Leipzig University, Institute of Pharmacy and Institute for Medical Physics and Biophysics)
2010 - 2011 European Medicines Agency, HMPC secretariat, London, UK
2010 Diploma in Pharmacy (University of Florida, Gainesville, FL, USA, in cooperation with Leipzig University
2009 Graduation in Pharmacy (Leipzig University)
2007 - 2010 Student Assistant (Leipzig University, Institute of Pharmacy and Institute for Medical Informatics, Statistics and Epidemiology)

Nach oben

Memberships in Learned Societies

  • Advisory Board member for the Society for Medicinal Plant and Natural Product Research (Gesellschaft für Arzneipflanzen- und Naturstoff-Forschung e.V.)
  • Mitglied für den Fachbereich Pharmakologie/Toxikologie der Kommission nach § 25 Abs. 6 und 7 des Arzneimittelgesetzes für den humanmedizinischen Bereich, phytotherapeutische Therapierichtung (Kommission E) am Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn
  • Deutsche Pharmazeutische Gesellschaft
  • Deutsche Gesellschaft für Viszeral- und Stoffwechselkrankheiten
  • Society for Medicinal Plant and Natural Product Research (Advisory Board Member)
  • Deutsche Gesellschaft für Neurogastroenterologie und Motilität

Publications

  1. Vissiennon, C., Nieber, K., Kelber, O., Butterweck, V. Route of administration determines the anxiolytic activity of the flavonols kaempferol, quercetin and myricetin — are they prodrugs? J Nutr Biochem 23 (2012), 733–740.
  2. Vissiennon, C., Goos, K.-H., Goos, O., Nieber, K. Antispasmodic effects of myrrh due to calcium antagonistic effects in inflamed rat small intestinal preparations. Planta Med 81 (2015), 116–122.
  3. Marquardt, P., Vissiennon, C., Nieber, K., 2015. Medicinal plants in Benin: An analysis of traditionally used Beninese plants indexed in the Prota Database. Planta Med 81 (2015).
  4. Vissiennon C., Goos, K.H., Arnhold, J., Nieber, K., 2017. Mechanisms on spasmolytic and anti-inflammatory effects of a herbal medicinal product consisting of myrrh, chamomile flower, and coffee charcoal. Wien Med Wochenschr 167 (2017) 169-176.
  5. Vissiennon C., Hammoud, D., Goos KH., Nieber K., Arnhold J., 2017. Synergistic interactions of chamomile flower, myrrh and coffee charcoal in inhibiting pro-inflammatory chemokine release from activated human macrophages. Synergy 4 (2017) 13-18.
  6. Vissiennon, C., Hammoud, D., Rodewald S., Fester K., Goos KH., Nieber K., Arnhold J. Chamomile Flower, Myrrh, and Coffee Charcoal, Components of a Traditional Herbal Medicinal Product, Diminish Proinflammatory Activation in Human Macrophages. Planta Med. 83 (2017) 846-854.
  7. Vissiennon, C., Hammoud, D., Goos, K.-H., Nieber, K., Arnhold, J. Synergistic interactions of chamomile flower, myrrh and coffee charcoal in inhibiting pro-inflammatory chemokine release from activated human macrophages. Synergy 4 (2017) 13-18. [DOI]
  8. Weber, L., Hammoud Mahdi, D., Jankuhn, S., Lipowicz, B., Vissiennon, C. Bioactive plant compounds in coffee charcoal (coffeae carbo) extract inhibit cytokine release from activated human THP-1 macrophages. Molecules 24 (2019) e4263. [DOIPubMed]
  9. Hammoud Mahdi, D., Hubert, J., Renault, J.H., Martinez, A., Schubert, A., Engel, K.M., Koudogobo, B., Vissiennon, Z., Ahyi, V., Nieber, K., Vissiennon, C. Chemical profile and antimicrobial activity of the fungus-growing termite strain macrotermes bellicosus used in the traditional medicine in the Republic of Benin. Molecules 25 (2020) 5015. [DOIPubMed]
  10. Marquardt, P., Vissiennon, C., Schubert, A., Birkemeyer, C., Ahyi, V., Fester, K. Phytochemical analysis, in vitro anti-inflammatory and antimicrobial activity of piliostigma thonningii leaf extracts from Benin. Planta Med 86 (2020) 1269-1277. [DOIPubMed]
  11. Weber, L., Kuck,. K., Jürgenliemk, G., Heilmann, J., Lipowicz, B., Vissiennon, C. Anti-inflammatory and barrier-stabilising effects of myrrh, coffee charcoal and chamomile flower extract in a co-culture cell model of the intestinal mucosa. Biomolecules 10 (2020) 1033. [DOIPubMed]
  12. Hammoud Mahdi, D., Wissenbach, D.K., von Bergen, M., Vissiennon, Z., Chougourou, D., Nieber, K., Ahyi, V., Vissiennon, C. Ethnomedicinal survey and in vitro confirmation of anti-inflammatory and antispasmodic properties of the termite strain macrotermes bellicosus used in traditional medicine in the Republic of Benin. J Ethnopharmacol. 254 (2020) 112705. [DOIPubMed]
  13. Marquardt, P., Seide, P., Vissiennon, C., Schubert, A., Birkemeyer, C., Ahyi, V., Fester, K.  Phytochemical characterization and in vitro anti-inflammatory, antioxidant and antimicrobial activity of combretum collinum fresen leaves extracts from Benin. Molecules 25 (2020) 288. [DOIPubMed]
  14. Roerig, J., Schiller, L., Kalwa, H., Hause, G., Vissiennon, C., Hacker, M.C., Wölk, C., Schulz-Siegmund, M. A focus on critical aspects of uptake and transport of milk-derived extracellular vesicles across the Caco-2 intestinal barrier model. Eur. J. Pharm. Biophar. 166 (2021) 61-74. [DOI, PubMed]
letzte Änderung: 28.07.2021